Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy (Q37124765)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2016

Language	Label	Description	Also known as
English	Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy	scientific article published on September 2016

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy (English)

1 reference

Europe PubMed Central

18 August 2017

0 references

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Xu Guang Hu

1

1 reference

Europe PubMed Central

18 August 2017

Wei Mao

2

1 reference

Europe PubMed Central

18 August 2017

Yong Keun Park

3

1 reference

Europe PubMed Central

18 August 2017

Wei Guang Xu

4

1 reference

Europe PubMed Central

18 August 2017

Bong Wan Kim

5

1 reference

Europe PubMed Central

18 August 2017

Hee Jung Wang

6

1 reference

Europe PubMed Central

18 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2016

1 reference

Europe PubMed Central

18 August 2017

Yonsei Medical Journal

1 reference

Europe PubMed Central

18 August 2017

57

1 reference

Europe PubMed Central

18 August 2017

5

1 reference

Europe PubMed Central

18 August 2017

1115-1123

1 reference

Europe PubMed Central

18 August 2017

Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

The linkage between inflammation and Type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Immunity, Inflammation, and Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Current status of liver diseases in Korea: hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Inflammation and cancer: back to Virchow?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

29 September 2017

Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

27 June 2018

The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

27 June 2018

Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

27 June 2018

Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence of hepatocellular carcinoma after surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of neutrophils by recombinant interleukin 6

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Clinical features of hepatocellular carcinoma in the 1990s]

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3349/YMJ.2016.57.5.1115

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37124765&oldid=1634220072"